Calumet, Inc. (NASDAQ:CLMT) Sees Large Growth in Short Interest

Calumet, Inc. (NASDAQ:CLMT) was the target of a large growth in short interest in February. As of February 13th, there was short interest totaling 6,970,191 shares, a growth of 21.1% from the January 29th total of 5,755,371 shares. Based on an average daily volume of 1,580,686 shares, the days-to-cover ratio is currently 4.4 days. Approximately 8.4% of the shares of the company are sold short. Approximately 8.4% of the shares of the company are sold short. Based on an average daily volume of 1,580,686 shares, the days-to-cover ratio is currently 4.4 days.

Institutional Trading of Calumet

A number of hedge funds and other institutional investors have recently modified their holdings of CLMT. Great Lakes Advisors LLC bought a new position in shares of Calumet in the 3rd quarter valued at $3,088,000. Two Seas Capital LP increased its holdings in Calumet by 56.9% in the 2nd quarter. Two Seas Capital LP now owns 4,497,609 shares of the oil and gas company’s stock worth $70,860,000 after purchasing an additional 1,631,098 shares in the last quarter. Intech Investment Management LLC bought a new position in Calumet in the second quarter valued at about $518,000. AYAL Capital Advisors Ltd acquired a new stake in shares of Calumet during the second quarter valued at about $5,278,000. Finally, SP Asset Management LLC acquired a new stake in shares of Calumet during the second quarter valued at about $205,000. Institutional investors own 34.41% of the company’s stock.

Calumet Stock Up 5.1%

Calumet stock opened at $29.32 on Thursday. The stock has a market cap of $2.54 billion, a PE ratio of -75.18 and a beta of 1.18. Calumet has a 12-month low of $7.68 and a 12-month high of $30.35. The business’s 50-day moving average price is $23.56 and its two-hundred day moving average price is $20.25.

Calumet (NASDAQ:CLMT) last posted its earnings results on Friday, February 27th. The oil and gas company reported ($0.43) EPS for the quarter, topping analysts’ consensus estimates of ($0.67) by $0.24. The company had revenue of ($3,098.50) million during the quarter, compared to the consensus estimate of $1.04 billion. During the same period last year, the company posted ($0.47) EPS. The firm’s revenue was up 9.4% compared to the same quarter last year. As a group, analysts expect that Calumet will post -3.02 earnings per share for the current year.

Trending Headlines about Calumet

Here are the key news stories impacting Calumet this week:

• Positive Sentiment: HC Wainwright maintains a “Buy” rating and a $33 price target on CLMT, signaling continued analyst conviction in upside to the share price despite near‑term weakness. MarketBeat: CLMT coverage
• Positive Sentiment: HC Wainwright’s long‑run modeling is bullish: the firm projects material recovery by FY2029–FY2030 (FY2030 EPS forecast of $3.57), which can support speculative/investment interest in CLMT as a turnaround play. MarketBeat: CLMT coverage
• Neutral Sentiment: Reported short‑interest entries for early March show anomalous/zero values (0 shares / NaN changes); the data looks unreliable and does not provide a clear signal about bearish positioning or squeeze risk. (Source: internal short‑interest entries)
• Neutral Sentiment: Sector/industry note — TRUFUEL announced record monthly sales, reflecting strength in fuel demand for certain end markets; this is industry‑level color but not directly tied to Calumet’s corporate updates. TRUFUEL Press Release
• Negative Sentiment: HC Wainwright sharply reduced near‑term EPS expectations: FY2026 EPS lowered to ($2.32) from ($1.22), FY2027 cut to ($0.12) from $0.23, and FY2028 trimmed to $0.98 from $1.35. Quarterly EPS forecasts for 2026 are loss‑making across Q1–Q4 per the note. These downgrades increase short‑term downside risk to profits and can weigh on valuation until visibility improves. MarketBeat: CLMT coverage

Analysts Set New Price Targets

CLMT has been the subject of a number of analyst reports. UBS Group reiterated a “neutral” rating and issued a $26.00 price target on shares of Calumet in a research report on Friday, February 13th. Weiss Ratings reaffirmed a “sell (d-)” rating on shares of Calumet in a report on Monday, December 29th. TD Cowen reiterated a “hold” rating on shares of Calumet in a research report on Thursday, January 29th. HC Wainwright reissued a “buy” rating and set a $33.00 target price on shares of Calumet in a report on Monday, November 10th. Finally, The Goldman Sachs Group boosted their price target on Calumet from $20.00 to $24.00 and gave the company a “buy” rating in a research note on Friday, January 30th. Four investment analysts have rated the stock with a Buy rating, three have assigned a Hold rating and one has issued a Sell rating to the company’s stock. According to MarketBeat, the company currently has a consensus rating of “Hold” and an average price target of $22.83.

Calumet Company Profile

Calumet Specialty Products Partners, L.P. (NASDAQ: CLMT) is an independent provider of high-value, essential product solutions derived from both petroleum and renewable feedstocks. The company operates an integrated network of manufacturing plants, blending terminals and storage facilities across North America, delivering customized products and technical services to industrial, automotive, consumer and agricultural end markets. By leveraging its scale and technical expertise, Calumet tailors supply chain and formulation solutions to meet stringent regulatory and performance requirements.

Calumet’s product portfolio includes specialty lubricants and base oils for high-performance applications; process oils and waxes for food-grade, cosmetic and packaging uses; industrial solvents and cleaning solutions; and fuel additives designed to optimize engine performance and emissions.